Project: Advanced in vivo imaging service for preclinical models to improve therapies in Autoimmune Diseases

The consortium offers services of advanced in vivo imaging analysis in preclinical animal models of autoimmune conditions, including specialised models of orphan diseases, for the pharmaceutical industry. The inclusion of in vivo imaging of joint and CNS pathologies in whole animals, often requested by customers for drug evaluation, provides a more detailed and extensive evaluation of new drugs and improves the selection of the best drugs for further development and clinical trials.

Acronym IMAID (Reference Number: 9215)
Duration 01/01/2015 - 01/01/2017
Project Topic Biological Sciences / Technologies
Network Eurostars 2
Call Eurostars Cut-Off 2

Project partner

Number Name Role Country
19932 Redoxis AB Coordinator Sweden
19933 Image Analysis Partner United Kingdom